PCMA: Butterfield Bill Would Increase Pharmacy Costs, Undermine Unions and Employers
November 17, 2009
(Washington, DC)- The Pharmaceutical Care Management Association (PCMA) issued the following statement regarding the introduction of the “Patient Health & Real Medication Access Cost Savings Act of 2009,” by Representative G.K. Butterfield (D – NC):
“At a time when all of Washington wants to reduce the cost of health care, the Butterfield legislation would destroy proven cost-containment tools that unions, large employers, and Medicare rely upon and drive premiums higher for working families, seniors, and the disabled.
“The Butterfield legislation would:
- Prohibit unions and employers from creating benefit designs that encourage generic utilization and other cost saving tools.
- Force patients to pay a 20 percent co-insurance for both brand and generic drugs, eliminating the numerous free or reduced-cost drug programs available to those suffering from chronic conditions.
- Impose unrealistic federal price controls.
- Mandate that unions and employers increase payments to drug stores.
- Add new barriers to prevent consumers from using more convenient options like home delivery.”